[ Price : $8.95]
A study in the latest issue of Archives of Internal Medicine questions the value of quarterly MedWatch postings of new drug safety...[ Price : $8.95]
A new report from IMS Institute for Healthcare Informatics recommends that FDA or the healthcare industry establish an early warni...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on information collection requirements for reclassification petitions for medical devi...[ Price : $8.95]
Federal Register Notice: FDAs Advisory Committee for Reproductive Health Drugs will meet 1/20/12 to discuss Columbia Labs NDA for ...[ Price : $8.95]
Genzyme says it will submit an NDA during the first quarter of 2012 for its multiple sclerosis therapy Lemtrada following favorabl...[ Price : $8.95]
FDA review documents released before an advisory committee meeting appear to support expanded use of Wyeths Prevnar 13 in adults a...[ Price : $8.95]
FDA commissioner Margaret Hamburg telsl cancer researcher FDA is finalizing a guidance on streamlining data collection in late sta...[ Price : $8.95]
FDA accepts a supplemental NDA from NeurogesX, Inc. for a 30-minute application of its Qutenza 8% for managing neuropathic pain as...